Loading clinical trials...
Loading clinical trials...
This study is designed to explore the expression of cell-surface markers in the following seven disease areas: (a) systemic lupus erythematosus, (b) Sjogren's syndrome, (c) multiple sclerosis, (d) sys...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alpine Immune Sciences, Inc.
NCT06433752 · Relapsing Multiple Sclerosis, Multiple Sclerosis
NCT07409181 · Systemic Lupus Erythematosus
NCT07043153 · Systemic Lupus Erythematosus Disease
NCT06846281 · Relapsing Multiple Sclerosis
NCT05644522 · Cerebrovascular Accident, Post-polio Syndrome, and more
GI Research Institute
Vancouver, British Columbia
Mary Pack Arthritis Center
Vancouver
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions